Indalo Therapeutics
develops novel integrin antagonists therapies for the treatment of fibrotic diseases... Read moreIndalo Therapeutics
develops novel integrin antagonists therapies for the treatment of fibrotic diseases... Read more
News
Nov 11, 2019
PR Newswire
Press Release: Indalo Therapeutics : Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965
Oct 21, 2019
PR Newswire
Press Release: Indalo Therapeutics : Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965
Apr 18, 2019
PR Newswire
Press Release: Indalo Therapeutics : Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965
Aug 02, 2017
The Business Journals
Indalo Therapeutics: Biotech startup raises some of $26 million funding round
Indalo Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10